Dissociable noradrenergic and cholinergic contributions to cognitive function in early Parkinson's disease: A free-water imaging study.
Abstract
Objective
To distinguish the roles of the noradrenergic locus coeruleus (LC) and cholinergic systems (nucleus basalis of Meynert [NBM], pedunculopontine nucleus [PPN]) in early Parkinson's disease (PD) cognitive impairment using free-water imaging (FWf).
Methods
FWf metrics were derived from the LC and cholinergic pathways via probabilistic tractography in 114 de novo PD patients from the Parkinson's Progression Markers Initiative. Cross-sectional, linear mixed-effects, and Cox models assessed associations with cognition and progression to cognitive/functional decline over 5 years.
Results
Cross-sectionally, LC integrity specifically linked to visuospatial function (BJLO), while NBM lateral pathway integrity uniquely associated with processing speed (SDMT). LC showed stronger associations with HVLT immediate recall, NBM with HVLT discrimination. Longitudinally, baseline LC FWf predicted declines in semantic fluency (β = -0.124, P = 0.016) and immediate verbal recall (β = -0.131, P = 0.007); NBM lateral FWf predicted decline in verbal discrimination (β = -0.078, P = 0.021). NBM lateral FWf independently predicted onset of cognitive impairment (HR = 1.72, 95% CI:1.07-2.77, P = 0.026) and functional decline (HR = 2.57, P = 0.021). Conventional DTI metrics (MD, AD, RD) in the NBM lateral pathway consistently predicted both endpoints.
Conclusions
LC-noradrenergic and NBM-cholinergic systems show dissociable cognitive contributions in early PD: LC integrity broadly associates with multiple domains cross-sectionally, whereas cholinergic pathway integrity-especially NBM lateral projections-emerges as a robust predictor of future cognitive and functional decline.